Durvalumab in Combination with Olaparib in Patients with Relapsed Small Cell Lung Cancer: Results from a Phase II Study

出版年份 2019 全文链接

标题

作者

关键词

Small cell lung cancer, PARP inhibitors, immune checkpoint blockade, tumor immune phenotype, DNA repair

出版物

Volume -, Issue -, Pages -

出版商

Elsevier BV

发表日期

2019-05-09

DOI

10.1016/j.jtho.2019.04.026

联系作者

Explore over 38,000 international journals covering a vast array of academic fields.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started